Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis

BACKGROUND: Although the current standard preoperative chemoradiotherapy (PCRT) for stage II/III rectal cancer decreases the risk of local recurrence, it does not improve survival and increases the likelihood of preoperative overtreatment, especially in patients without circumferential resection mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jii Bum, Kim, Han Sang, Ham, Ahrong, Chang, Jee Suk, Shin, Sang Jun, Beom, Seung-Hoon, Koom, Woong Sub, Kim, Taeil, Han, Yoon Dae, Han, Dai Hoon, Hur, Hyuk, Min, Byung Soh, Lee, Kang Young, Kim, Nam Kyu, Park, Yu Rang, Lim, Joon Seok, Ahn, Joong Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848147/
https://www.ncbi.nlm.nih.gov/pubmed/33537238
http://dx.doi.org/10.3389/fonc.2020.609313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848147/
https://www.ncbi.nlm.nih.gov/pubmed/33537238
http://dx.doi.org/10.3389/fonc.2020.609313

Ejemplares similares